Better Stroke Treatment
MedStar Southern Maryland Hospital Center Receives Quality Achievement Award For Stroke Care
American Heart Association Award recognizes MedStar Southern Maryland Hospital Center’s commitment to quality stroke care
There’s no substitute for being ready for a major health event. MedStar Southern Maryland Hospital Center (MSMHC) has developed its level of care in the area of stroke support so much so it has received a national award in that area.
MedStar’s MSMHC has received the American Heart Association/American Stroke Association’s Get With The Guidelines Target: Stroke Honor Roll Elite Plus Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.
MSMHC earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.
“MSMHC is dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association’s Get With The Guidelines-Stroke initiative,” said MSMHC President Christine Wray. “The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes.”
MSMHC additionally received the association’s Target: StrokeSM Elite Plus award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or TPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.